Voltaren Topical Pain Relief Gel

Voltaren gel delivers targeted pain relief directly to joints and muscles, making it a go-to option for millions managing arthritis and strains.

Updated: 05/14/2026

By Elena Martinez, Senior Product Editor - covering pharmaceuticals and consumer health products.

What Voltaren Topical Pain Relief Gel Is and How It Works

Voltaren Topical Pain Relief Gel is a non-steroidal anti-inflammatory drug (NSAID) formulated as a clear, fragrance-free gel. Its active ingredient, 1% diclofenac sodium, penetrates the skin to reduce inflammation and pain at the source in muscles and joints. Unlike oral painkillers, it delivers medication locally, limiting exposure to the stomach and other organs.

Users apply a dime-sized amount up to four times daily to the affected area, rubbing it in gently. The gel dries quickly, leaving no greasy residue, and starts working within hours. Clinical studies show it provides relief comparable to oral ibuprofen for osteoarthritis knee pain, with fewer gastrointestinal side effects.

The gel's advanced formula includes isopropyl alcohol for fast drying and penetration enhancers to drive diclofenac through the skin layers. It targets cyclooxygenase enzymes at the injury site, blocking prostaglandin production that causes swelling and discomfort.

Why Voltaren Topical Pain Relief Gel Matters for Consumers and Industry

For consumers, Voltaren offers a safer alternative to pills for chronic conditions like osteoarthritis, affecting over 32 million US adults. It empowers active lifestyles by relieving pain from exercise, work, or daily tasks without drowsiness or stomach upset risks common in oral NSAIDs.

In the $75 billion global pain relief market, Voltaren stands out as the first OTC prescription-strength topical NSAID in the US, approved by the FDA in 2020. This shift reduces doctor visits and prescription needs, appealing to aging populations seeking non-opioid options amid the opioid crisis.

Industry-wide, it highlights the rise of topical therapies, with sales growing 15% annually. Brands like Voltaren drive innovation in transdermal delivery, influencing formulations for other conditions like back pain and sprains.

Voltaren Topical Pain Relief Gel in the Global Market

Voltaren leads the topical NSAID segment, available OTC in over 100 countries. In the US, it captured 40% market share post-launch, per Nielsen data, outperforming patches and creams due to ease of use and proven efficacy.

Competition includes generics like diclofenac sodium gel and rivals such as Bengay or Icy Hot, but Voltaren's brand trust and clinical backing give it an edge. Supply chains rely on Haleon's global manufacturing, ensuring steady availability despite raw material fluctuations.

Regulatory approvals span FDA, EMA, and Health Canada, with ongoing studies exploring higher strengths and combo formulas. Adoption surges among athletes and seniors, with e-commerce boosting access in emerging markets.

Voltaren Topical Pain Relief Gel is produced by Haleon, the consumer health giant spun off from GSK in 2022, which holds global rights outside certain licensed regions.

The product ties to Haleon shares listed on the London Stock Exchange under ISIN CH0012005267, reflecting the company's broader consumer health portfolio.

Disclaimer: This article is not investment advice. Stocks are volatile financial instruments.